MD vs HCA

For growth investors, HCA Healthcare, Inc.

(HCA) is the stronger pick with 7. 1% revenue growth year-over-year, versus -4. 9% for Pediatrix Medical Group, Inc. (MD). Pediatrix Medical Group, Inc. (MD) offers the better valuation at 11. 8x trailing P/E (10. 3x forward), making it the more compelling value choice. Analysts rate HCA Healthcare, Inc. (HCA) a "Buy" — based on 46 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Pediatrix Medical Group, Inc.

(MD) is the cheapest at 11. 8x versus HCA Healthcare, Inc. at 15. 1x. On forward P/E, Pediatrix Medical Group, Inc. is actually cheaper at 10. 3x.

Over the past 5 years, HCA Healthcare, Inc.

(HCA) delivered a total return of +109. 7%, compared to -28. 6% for Pediatrix Medical Group, Inc. (MD). Over 10 years, the gap is even starker: HCA returned +450. 5% versus MD's -67. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), HCA Healthcare, Inc.

(HCA) is the lower-risk stock at 0. 29β versus Pediatrix Medical Group, Inc. 's 0. 73β — meaning MD is approximately 153% more volatile than HCA relative to the S&P 500.

By revenue growth (latest reported year), HCA Healthcare, Inc.

(HCA) is pulling ahead at 7. 1% versus -4. 9% for Pediatrix Medical Group, Inc. (MD). On earnings-per-share growth, the picture is similar: Pediatrix Medical Group, Inc. grew EPS 263. 0% year-over-year, compared to 29. 0% for HCA Healthcare, Inc.. Over a 3-year CAGR, HCA leads at 7. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

HCA Healthcare, Inc.

(HCA) is the more profitable company, earning 9. 0% net margin versus 8. 6% for Pediatrix Medical Group, Inc. — meaning it keeps 9. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HCA leads at 15. 8% versus 12. 1% for MD. At the gross margin level — before operating expenses — HCA leads at 41. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Pediatrix Medical Group, Inc.

(MD) trades at 10. 3x forward P/E versus 14. 2x for HCA Healthcare, Inc. — 3. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HCA: 22. 9% to $527. 45.

In this comparison, HCA (0.

7% yield) pays a dividend. MD does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, HCA Healthcare, Inc.

(HCA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 29), 0. 7% yield, +450. 5% 10Y return). Both have compounded well over 10 years (HCA: +450. 5%, MD: -67. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

HCA pays a dividend while MD does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.